Neuronix Overview
- Year Founded
-
2008

- Status
-
Out of Business
- Employees
-
16

- Latest Deal Type
-
Out of Business
Neuronix General Information
Description
Provider of a medical device to treat Alzheimer's Disease designed to treat mild to moderate Alzheimer's Disease in Europe. The company's neuroAD is based on the company's core Non Invasive patented technology and helps to reverse the effects Alzheimer's has on cognitive brain function, enabling health industries to offer hope and the potential for long-term improvement in the quality of life of patients.
Contact Information
Website
www.neuronixmedical.comCorporate Office
- HaCarmel 5
- Yokneam 20692
- Israel
Corporate Office
- HaCarmel 5
- Yokneam 20692
- Israel
Neuronix Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Out of Business | 01-Nov-2020 | Completed | Out of Business | |||
5. Later Stage VC | 01-Jan-2016 | Completed | Profitable | |||
4. Later Stage VC | 18-Feb-2014 | Completed | Profitable | |||
3. IPO | 05-May-2013 | Cancelled | Startup | |||
2. Merger/Acquisition | $10M | Completed | Startup | |||
1. Angel (individual) | Completed | Startup |
Neuronix Comparisons
Industry
Financing
Details
Neuronix Competitors (1)
One of Neuronix’s competitors is Boston Scientific, a Corporation company based in Marlborough, MA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Boston Scientific | Corporation | Marlborough, MA |
Neuronix Patents
Neuronix Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20140179981-A1 | Method and system for positioning a transcranial magnetic stimulation (tms) device | Inactive | 01-Nov-2010 | ||
EP-2414038-A1 | Method and system for neurological treatment | Active | 03-Apr-2009 | ||
EP-2414038-B1 | System for neurological treatment | Inactive | 03-Apr-2009 | ||
US-8591392-B2 | Method and system for neurological treatment | Active | 03-Apr-2009 | ||
ES-2557514-T3 | Neurological treatment system | Active | 03-Apr-2009 | G09B23/28 |
Neuronix Signals
Neuronix FAQs
-
When was Neuronix founded?
Neuronix was founded in 2008.
-
Where is Neuronix headquartered?
Neuronix is headquartered in Yokneam, Israel.
-
What is the size of Neuronix?
Neuronix has 16 total employees.
-
What industry is Neuronix in?
Neuronix’s primary industry is Therapeutic Devices.
-
Is Neuronix a private or public company?
Neuronix is a Private company.
-
What is Neuronix’s current revenue?
The current revenue for Neuronix is
. -
How much funding has Neuronix raised over time?
Neuronix has raised $7.5M.
-
Who are Neuronix’s competitors?
Boston Scientific is a competitor of Neuronix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »